Skip to content

Onto Innovation ONTO Proceeds from exercises of stock options and other stock issuances

Proceeds from exercises of stock options and other stock issuances at other companies

Teradyne, Inc. logo
Teradyne, Inc.TER
$15.1M+2.1%
Amkor Technology logo
Amkor TechnologyAMKR
MACOM Technology Solutions logo
MACOM Technology SolutionsMTSI

Other financials

Income statement

See full
Revenue$291.9M+9.5%
Gross profit$146.4M+2.2%
Operating income$33.5M-46.9%
Net income$33.8M-1.3%
EPS (diluted)$0.67-48.5%

Balance sheet

See full
Cash & equivalents$252.2M+23.8%
Total debt$17.5M+15.3%
Total equity$2.1B+11.1%
Total assets$2.4B+13.3%

Cash flow

See full
Operating cash flow$26.3M-71.4%
CapEx$3.6M-56.5%
Free cash flow$22.7M-72.9%

Valuation

See full
Market cap$16.6B+70.5%
P/E121.8×+69.3×
P/S16.1×+6.6×

Profitability

See full
Gross margin48.8%-3.9pp
Operating margin10%-10.2pp
Net margin13.2%-4.9pp

Returns & leverage

See full
Return on equity6.7%-3.3pp
Debt / equity0.0×
Current ratio6.2×-2.3×

Where this comes from

Reported directly by Onto Innovation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Onto Innovation’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Onto Innovation's proceeds from exercises of stock options and other stock issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Onto Innovation's proceeds from exercises of stock options and other stock issuances?
Onto Innovation (ONTO) reported proceeds from exercises of stock options and other stock issuances of $0 in Q1 2026.
How has Onto Innovation's proceeds from exercises of stock options and other stock issuances changed year-over-year?
Onto Innovation's proceeds from exercises of stock options and other stock issuances decreased by 100.0% year-over-year, from $4.18M to $0.
What is the long-term trend for Onto Innovation's proceeds from exercises of stock options and other stock issuances?
Over 2 years (2021 to 2025), Onto Innovation's proceeds from exercises of stock options and other stock issuances has grown at a 15.3% compound annual growth rate (CAGR), from $10.07M to $13.4M.